Unknown

Dataset Information

Adverse outcome pathway development II: best practices.


ABSTRACT: Organization of existing and emerging toxicological knowledge into adverse outcome pathway (AOP) descriptions can facilitate greater application of mechanistic data, including those derived through high-throughput in vitro, high content omics and imaging, and biomarker approaches, in risk-based decision making. The previously ad hoc process of AOP development is being formalized through development of internationally harmonized guidance and principles. The goal of this article was to outline the information content desired for formal AOP description and some rules of thumb and best practices intended to facilitate reuse and connectivity of elements of an AOP description in a knowledgebase and network context. For example, key events (KEs) are measurements of change in biological state that

SUBMITTER: Villeneuve DL 

PROVIDER: S-EPMC4318924 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature